Working… Menu

Nivolumab in Treating Patients With High-Risk Kidney Cancer Before Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02595918
Recruitment Status : Terminated (Inadequate accrual rate)
First Posted : November 4, 2015
Last Update Posted : October 23, 2020
Information provided by (Responsible Party):
National Cancer Institute (NCI)

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : August 1, 2020
Actual Study Completion Date : August 1, 2020